Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NLTX - Citigroup sees 36% upside in Amarin in premarket analyst action

NLTX - Citigroup sees 36% upside in Amarin in premarket analyst action

Neoleukin Therapeutics Inc.
  • Neoleukin  Therapeutics (NASDAQ:NLTX) initiated with Buy rating and $20 (82% upside) price target at Guggenheim.
  • More news on: Xeris Pharmaceuticals, Inc., Neoleukin Therapeutics, Inc., Amarin Corporation plc, Healthcare stocks news, Stocks on the move, ,
    • Read more ...
Stock Information
Company Name: Neoleukin Therapeutics Inc.
Stock Symbol: NLTX
Market: NYSE
Menu
NLTX NLTX Quote NLTX Short NLTX News NLTX Articles NLTX Message Board
Get NLTX Alerts

News, Short Squeeze, Breakout and More Instantly...